Skip to main content
Figure 1 | Journal of Translational Medicine

Figure 1

From: PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy

Figure 1

Representative MSP assay for PTPRO gene methylation in FFPE specimens of normal adjacent tissues and tumors from breast cancer patients. Numbers on top indicate sample number. NATs, Normal adjacent tissues; Mc, methylated control, paraffin blocks of MCF-7 human cancer cells; Uc, unmethylated control, paraffin blocks of NE-2 immortalized normal cells; M, methylated; U, unmethylated; Mk, DNA markers.

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us